Resistance patterns associated with HCV NS5A inhibitors provide limited insight into drug binding.
Resistance patterns associated with HCV NS5A inhibitors provide limited insight into drug binding.
复制标题
DOI：
10.3390/v6114227
复制
发表时间：
2014-11-06
期刊：
影响因子：
--
通讯作者：
Götte M
中科院分区：
文献类型：
--
作者：
Issur M;Götte M
Direct-acting antivirals (DAAs) have significantly improved the treatment of infection with the hepatitis C virus. A promising class of novel antiviral agents targets the HCV NS5A protein. The high potency and broad genotypic coverage are favorable properties. NS5A inhibitors are currently assessed in advanced clinical trials in combination with viral polymerase inhibitors and/or viral protease inhibitors. However, the clinical use of NS5A inhibitors is also associated with new challenges. HCV variants with decreased susceptibility to these drugs can emerge and compromise therapy. In this review, we discuss resistance patterns in NS5A with focus prevalence and implications for inhibitor binding.
登录
查看更多内容
影响因子：
3.7
作者：
Coelmont L;Hanoulle X;Chatterji U;Berger C;Snoeck J;Bobardt M;Lim P;Vliegen I;Paeshuyse J;Vuagniaux G;Vandamme AM;Bartenschlager R;Gallay P;Lippens G;Neyts J
通讯作者：
Neyts J
影响因子：
5.9
作者：
Goette, Matthias
通讯作者：
Goette, Matthias
影响因子：
4.9
作者：
Fridell, Robert A.;Qiu, Dike;Gao, Min
通讯作者：
Gao, Min
影响因子：
5.6
作者：
Barakat, Khaled H.;Anwar-Mohamed, Anwar;Houghton, Michael
通讯作者：
Houghton, Michael
DOI：
10.1073/pnas.1203110110
发表时间：
2013-03-05
影响因子：
11.1
作者：
Guedj, Jeremie;Dahari, Harel;Perelson, Alan S.
通讯作者：
Perelson, Alan S.